Anterior cervical discectomy and fusion solely with peek cages ın multilevel cervical spondylotic radiculomyelopathy: single center clinical experience with 58 consecutive patients

Aim of this study was to evaluate the efficacy and safety of fusion solely with polyetheretherketone (PEEK) cages without plates and autogenous bone graft to provide fusion in multilevel cervical spondylosis in selected cases. 58 patients with cervical discogenic disorders in 3-4 levels (38 and 20 patients respectively) underwent multilevel anterior cervical discectomy and fusion (ACDF) operations with PEEK cages for a total of 194 levels. Minimum follow up was 24 months postoperatively. Outcome had been established in combination with the evaluation of cervical lordosis, fusion rates and neurological improvement that was assessed by Japanese Orthopedic Association (JOA) scoring system. They were assessed by radiographs, computerized tomography and magnetic resonance imaging studies. Clinical outcomes were based on the issues including length of hospital stay, blood loss, complication rates and functional outcomes. 38 patients underwent three-level, 20 patients underwent four-level operations. Fusion rate was 89.2%. Significant improvement in the JOA scores was recorded postoperatively, and Ishihara Curvature Index (ICI) was preserved. In the follow-up period, no cage migration was experienced and reoperation was not required except for one who later underwent corpectomy and anterior fusion. ACDF with the use of PEEK cages without plates proved to yield good clinical outcome and comfortable postoperative course for the patients with acceptable fusion rates

___

  • 1. Olsson IM, Bensryd I, Lundh T, Ottosson H, Skerfving S, Oskarsson A. Cadmium in blood and urine–impact of sex, age, dietary intake, iron status, and former smoking–association of renal effects. Environ Health Perspect. 2002;110:1185-90.
  • 2. ATSDR Agency for Toxic Substances and Disease Registry, Toxicological Profile for Cadmium. U.S. Department of Health and Human Services. Public Health Service 1999a
  • 3. ATSDR Agency for Toxic Substances and Disease Registry, Toxicological Profile for Cadmium. U.S. Department of Health and Human Services. Public Health Service 2012
  • 4. Jarup L, Berglund M, Elinder CG, Nordberg G, Vahter M. Health effects of cadmium exposure-A review of the literature and a risk estimate. Scand J Work Environ Health. 1998;24(Suppl. 1):1-51.
  • 5. Järup L, Akesson A. Current status of Cd as an environmental health problem. Toxicol Appl Pharmacol. 2009;238:201-8.
  • 6. Peters JL, Perlstein TS, Perry MJ, McNeely E, Weuve J. Cadmium exposure in association with history of stroke and heart failure. Environ Res. 2010;110(2):199-206.
  • 7. Nishijo M, Nakagawa H, Morikawa Y, Tabata M, Senma M, Miura K, Takahara H, Kawano S, Nishi M, Mizukoshi K. Mortality of inhabitants in an area polluted by cadmium: 15 year follow up. Occup Environ Med. 1995;52(3):181-4.
  • 8. Carmignani M, Boscolo P. Cardiovascular responsiveness to physiological agonists of male rats made hypertensive by long-term exposure to cadmium. Sci Total Environ. 1984;34(1-2):19-33.
  • 9. Ronco AM, Montenegro M, Castillo P, Urrutia M, Saez D, Hirsch S, Zepeda R, Llanos MN. Maternal exposure to cadmium during gestation perturbs the vascular system of the adult rat offspring. Toxicol Appl Pharmacol. 2011;251(2):137-45.
  • 10. Zepeda R, Castillo P, Saez D, Llanos MN, Ronco AM. Cardiac tissue injury resistance during myocardial infarction at adulthood by developmental exposure to cadmium. Cardiovas Toxicol. 2012;12(1):64-72.
  • 11. Turdi S, Sun W, Tan Y, Yang X, Cai L and Ren J. Inhibition of DNA methylation attenuates low-dose cadmium-induced cardiac contractile and intracellular Ca2+ anomalies. Clinical and Experimental Pharmacology and Physiology. 2013;40(10):706-12.
  • 12. Tellez-Plaza M, Navas-Acien A, Menke A, Crainiceanu CM, PastorBarriuso R, Guallar E. Cadmium exposure and all-cause and cardiovascular mortality in the U.S. general population. Environ. Health Perspect. 2012;120(7):1017-22.
  • 13. Krantz A, Dorevitch S. Metal exposure and common chronic diseases: a guide for the clinician. Disease-a-Month. 2004;50(5):220-62.
  • 14. Carocci A, Catalano A, Lauria G, Sinicropi MS, Genchi G. Lead Toxicity, Antioxidant Defense and Environment Reviews of Environmental Contamination and Toxicology 2016;238:45-67.
  • 15. Markowitz M. Lead poisoning. Pediatr Rev. 2000;21:327-35.
  • 16. Begovic V, Nozic D, Kupresanin S, Tarabar D. Extreme gastric dilation caused by chronic lead poisoning: a case report. World J Gastroenterol. 2008;14(16):2599-01.
  • 17. Lyn Patrick, ND Lead Toxicity, A Review of the Literature.Part I: Exposure, Evaluation, and Treatment Alternative Medicine Review. 2006;11(1):1-22.
  • 18. Aoki Y, Brody DJ, Flegal KM, Fakhouri THI, Parker JD, Axelrad DA. Blood Lead and Other Metal Biomarkers as Risk Factors for Cardiovascular Disease Mortality. Medicine. 2016:95(1):1-8.
  • 19. Vaziri ND, Lin CY, Farmand F, Sindhu RK. Superoxide dismutase, catalase, glutathione peroxidase and NADPH oxidase in lead induced hypertension. Kidney Int. 2003;63(1):186-94.
  • 20. Fanning D. A mortality study of lead workers, 1926-1985. Arch Environ Health. 1988;43(3):247-51.
  • 21. Sokas RK, Simmens S, Sophar K. Lead levels in Maryland construction workers. Am J Ind Med. 1997;31(2):188-94.
  • 22. Staessen JA, Bulpitt CJ, Fagard R. Hypertension caused by lowlevel lead exposure: myth or fact? J Cardiovasc Risk. 1994;1(1):87- 97.
  • 23. Schwartz J. Lead, blood pressure, and cardiovascular disease in men. Arch Environ Health. 1995;50(1):31-7.
  • 24. Nawrot TS, Tiils L, Den Hond, EM. An epidemiological reappraisal of the association between blood pressure and blood lead: a metaanalysis. J Hum Hypertens. 2002;16(2):123-31.
  • 25. Lustberg M, Silbergeld E. Blood lead levels and mortality. Arch Intern Med. 2002;162(2):2443-9.
  • 26. Navas-Acien A, Selvin E, Sharrett AR, Calderon-Aranda E, Silbergeld E, Guallar E. Lead, cadmium, smoking, and increased risk of peripheral arterial disease. Circul. 2004;109(25):3196-201.
  • 27. Lukkhananan P, Thawonrachat N, Srihirun S, Swaddiwudhipong W, Chaturapanich G, Vivithanaporn P, Unchern S, Visoottiviseth P, Sibmooh N. Endothelial dysfunction in subjects with chronic cadmium exposure. J Toxicol Sci. 2015;40(5):605-13.
  • 28. National Center for Health Statistics. National Health and Nutrition Examination Survey, 1999–2000. Hyattsville, MD: National Center for Health Statistics, 2004. (http://www.cdc.gov/nchs/about/major/nhanes/nhanes99-00.htm)
  • 29. Bridges CC, Zalups RK. Molecular and ionic mimicry and the transport of toxic metals. Tox Appl Pharm. 2005;204:274-308.
  • 30. Zalups RK. Ahmad S. Molecular handling of cadmium in transporting epithelia. Tox Appl Pharm. 2003;186 (3):163-88.
  • 31. Prozialeck WC, Edwards JR, Woods JM. The vascular endothelium as a target of cadmium toxicity. Life Sci. 2006;79(16):1493-506.
  • 32. Gonick HC, Ding Y, Bondy SC, Ni Z, Vaziri ND. Lead-induced hypertension: interplay of nitric oxide and reactive oxygen species. Hypertension. 1997;30(6):1487-92.
  • 33. Bhatnagar A. Environmental Cardiology:Studying Mechanistic Links Between Pollution and Heart Disease. Circulation Research. 2006;99(7):692-705.
  • 34. Iwao S, Tsuchiya K, Sugita M. Variation of cadmium accumulation among Japanese.Arch Environ Health. 1983;38(3):156-62.
  • 35. CDC. Fourth Report on Human Exposure to Environmental Chemicals. Centers for Disease Control and Prevention. US Department of Health and Human Services. Atlanta, GA. 2009.
Medicine Science-Cover
  • ISSN: 2147-0634
  • Yayın Aralığı: Yılda 4 Sayı
  • Başlangıç: 2012
  • Yayıncı: Effect Publishing Agency ( EPA )